To: Paul Senior who wrote (29240 ) 12/15/2007 12:04:09 PM From: SI Bob Read Replies (2) | Respond to of 78711 Paul, ACAS even more confusing now. I'd dismissed its violating the lower trend line of higher lows because it'd similarly violated the upper line of higher highs. It's just getting more volatile, which has allowed me to trade it while maintaining a core position and even adding to it occasionally. What really puzzles me is that though it even more seriously violated the lower line yesterday (I added some but well above the low), immediately in afterhours it traded decent volume at much higher prices (and higher than the additional shares I bought), yet I can't find a fundamental event that would've/should've triggered that happening. Up 3% in afterhours, regaining substantially all that it'd given up during market hours, seems pretty significant to me. It didn't get back inside the channel, but a similar gain next week would put it there. Am I the only one kicking myself for realizing only in hindsight that BIIB was pretty richly priced? It wouldn't surprise me if its recent tankage was a life-changing event for some of the owners of puts. I'll continue to watch it pretty closely. When a pharma is trying very actively to get acquired and fails, I worry. A local company that used to trade under the ticker MKC (Marion Labs -- blockbuster drug Cardizem, and run by my personal hero whose leadership example I try to follow, the late Ewing Kaufmann) went through a similar situation but did get acquired. After the acquisition, it came out that in the opinion of many people, including its founder, it needed to be acquired to survive. This coming on the heels of a 3-year run in which it had 5 stock splits. The Kansas City area has many "Marion Millionaires" who were former employees.